Marchex (MCHX) Q1 2026 earnings review

A Huge Pivot Accompanied by the Lowest Revenue in Five Quarters

Marchex is selling a massive 'inflection point' narrative, but the current printed financials tell a different story. Q1 2026 revenue fell 7% YoY to $10.6M—the lowest level in over five quarters—as the hangover from the company's platform migration lingers. However, management is guiding for a drastic reversal. The impending acquisition of Archenia (expected to close in July 2026) and the rollout of new AI-verified outcome products have management projecting a sudden hockey-stick recovery in Adjusted EBITDA, guiding for $1.6M-$1.8M in Q2 and over $2.0M in Q3. Investors must decide if they trust the aggressive forward guidance or the persistently shrinking top line.

🐂 Bull Case

EBITDA Breakout Ahead

Guidance suggests Q2 Adjusted EBITDA will accelerate massively to $1.6-$1.8M (up from a prior estimate of >$1M), proving that recent operating leverage efforts are finally hitting the bottom line.

Archenia Deal Transforms the Business

The acquisition of Archenia aims to create a vertically focused, AI-driven platform with a $60M annualized revenue run rate. If successful, this instantly scales Marchex out of its micro-cap revenue rut.

🐻 Bear Case

Top-Line Decay Continues

Despite constant promises of a 'growth inflection,' standalone revenue has now decelerated sequentially for three consecutive quarters ($11.66M -> $11.51M -> $10.85M -> $10.62M).

Deal and Execution Risk

The entire bull thesis relies on closing a related-party acquisition (Archenia) and successfully shifting the customer base to unproven Pay-Per-Event models.

⚖️ Verdict: ⚪

Neutral. The forward EBITDA guidance is undeniably attractive, but the execution risk is extraordinarily high. Marchex is asking investors to ignore shrinking legacy revenue in favor of a related-party M&A transaction and unproven AI product adoption.

Key Themes

DRIVERNEW🟢

Archenia Acquisition as the Primary Catalyst

The cornerstone of Marchex's strategy is the definitive Stock Purchase Agreement to acquire Archenia. Archenia brings automated AI decisioning and outcome-based (Pay-Per-Event) campaign optimization. Management expects the combined entity to boast a ~$15M quarterly revenue run rate and grow 15-20% through 2026. This is the primary driver intended to reverse Marchex's stagnating standalone growth.

DRIVERNEW🟢

Conversational AI Agents Gaining Early Traction

The company has begun selling combined product offerings like Conversational AI Agents and AI-verified outcomes to its installed base. Management states they have presented to one-third of their top 100 customers, and roughly half of those have purchased on a recurring or paid pilot basis. This indicates strong early adoption of higher-margin, outcome-based SaaS tools.

DRIVER🟢

Underlying Operating Leverage

Despite the revenue decline, underlying profitability is accelerating. Q1 2026 Adjusted EBITDA was a loss of $0.1M, but this included $0.7M in reorganization costs. Excluding these, Adjusted EBITDA was a positive $0.6M. The projected leap to $1.6M-$1.8M in Q2 proves that the underlying cost structure has been successfully optimized.

CONCERN🔴🔴

Sequential Revenue Contraction Contradicts the Narrative

Management continuously promotes an 'inflection point', yet the data shows a deteriorating top line. Standalone revenue has decelerated for three straight quarters. At $10.6M in Q1 2026, revenue is down 7% YoY and notably below the $11.7M peak hit in Q2 2025. The platform migration ('OneStack') dilution is taking a heavier toll on legacy revenues than the new AI products are currently offsetting.

CONCERN🔴

Persistent 'Reorganization' Add-Backs

Adjusted EBITDA metrics must be heavily scrutinized. In Q4 2025, Marchex added back $1.6M in reorganization costs. In Q1 2026, they added back another $0.7M. If a company repeatedly incurs substantial 'one-time' reorganization expenses quarter after quarter, they begin to look like structural operating expenses.

CONCERN🔴

Archenia Deal Complexities and Related-Party Risks

The Archenia acquisition is a related-party transaction requiring approval from a special committee and a majority of disinterested stockholders. While the deal looks accretive on paper, related-party dynamics always introduce governance and valuation risks. Furthermore, combining two separate technology stacks often brings integration headaches that disrupt short-term execution.

THEME

Macro and Vertical-Specific Vulnerability

Marchex relies heavily on consumer intent verticals like automotive and home services. While management is attempting to shift to Pay-Per-Event models, these verticals remain highly sensitive to macroeconomic uncertainty, consumer discretionary spending, and supply chain disruptions (including recent tariff impacts flagged in prior quarters).

Other KPIs

Q1 2026 Revenue$10.62 million

Decelerating. Down 6.9% YoY from $11.4M in 25Q1, and down sequentially from $10.85M in 25Q4. This marks the lowest quarterly revenue level in over a year, underscoring the ongoing churn from legacy platform migrations.

Q1 2026 GAAP Net Loss$(1.72) million

Stable/Improving slightly. This is an improvement from the $(1.98)M loss in 25Q1 and the $(2.32)M loss in 25Q4, driven by lower overall operating expenses (down to $11.97M from $13.27M a year ago).

Cash and Cash Equivalents$9.02 million

Declining. Down from $9.94M at the end of 2025, and down significantly from $12.77M at the end of 2024. Monitoring liquidity is critical given the pending Archenia transaction and ongoing net losses.

Guidance

Q2 2026 Adjusted EBITDA$1.6 - $1.8 million

Accelerating drastically. Management revised this expectation upward from a prior baseline of 'more than $1 million'. This implies a massive sequential margin expansion and represents the core bull argument that cost-cutting and new product mix are finally yielding high-margin cash flow.

Q3 2026 Adjusted EBITDA (Stand-alone)~$2.0 million

Accelerating. Anticipated to grow sequentially from Q2, showing a continued ramp in operational leverage even without the Archenia integration.

Q3 2026 Adjusted EBITDA (Combined with Archenia)~$2.5 million

If the Archenia deal closes, management expects an immediate $0.5M quarterly EBITDA boost, bringing the annualized run rate to $10M+.

FY 2026 Revenue Run Rate~10% growth vs 2025 exit

Reversing. After three quarters of sequential contraction, management is guiding for sequential quarterly increases throughout 2026, leading to a 10% run-rate growth profile by year-end.

Key Questions

Platform Migration Churn

Revenue has contracted sequentially for three straight quarters. Has the legacy revenue dilution from the 'OneStack' migration fully bottomed out, or will it continue to offset the new AI product bookings in Q2 and Q3?

Reorganization Cost Add-Backs

The company added back $1.6M in Q4 and $0.7M in Q1 for 'reorganization' costs. Given the upcoming integration with Archenia, should investors expect these massive 'one-time' add-backs to become a permanent feature of Adjusted EBITDA?

Pay-Per-Event Economics

You noted that roughly half of the targeted top-tier customers are piloting Conversational AI Agents and AI-verified outcomes. What is the actual ACV (Annual Contract Value) uplift you are seeing when transitioning an existing 'insights' customer to a 'Pay-Per-Event' model?